Navigation Links
Two-Drug Treatment Didn't Improve Cardiac Arrest Survival Rates
Date:7/2/2008

But the case isn't closed, American cardiologists say

WEDNESDAY, July 2 (HealthDay News) -- Injecting the artery-constricting hormone vasopressin in addition to adrenaline did not improve survival among people who had sudden cardiac arrest in an European trial, but American cardiologists said the finding does not rule out use of that treatment in some cases.

The report comes from a group, primarily French, that several years ago described promising results of combining vasopressin and epinephrine -- the formal name of adrenaline -- as part of the emergency treatment of cardiac arrest. The American Heart Association responded to that report in guidelines saying that a first shot of vasopressin might be substituted for adrenaline, the traditional drug for cardiac arrest, in some cases.

But the latest report, on a total of nearly 3,000 people, found that "the combination of vasopressin and epinephrine during advanced cardiac life support for out-of-hospital cardiac arrest does not improve outcome." The study was published in the July 3 issue of the New England Journal of Medicine.

In each group, about one in five of those treated survived long enough to be admitted to a hospital -- 20.7 percent of the combined therapy group, 21.3 percent of the adrenaline-only group. The one-year survival rate was 1.3 percent for those given the two drugs, 2.1 percent of those given only adrenaline.

The reason for not giving up entirely on vasopressin is due to the average response time in the French study, said Dr. Joseph P. Ornato, chairman of emergency medicine at Virginia Commonwealth University, and a member of the committee that drew up the heart association guidelines.

"Paris is a city with a lot of traffic," Ornato said. "If you look at the time of collapse to the time of treatment, the first crew was at the scene in an average of 7.2 minutes. They didn't start to treat until 16.3 minutes. The first steady drug injection was not until 21 minutes."

That interval means everything, because "we lose roughly 10 percent of the odds of the resuscitation every minute," Ornato said.

In Richmond, "90 percent of the time, we respond within eight minutes or less," he said.

And so, Ornato said, "I am less than convinced that this completely answers the question, because I don't know what it means when your drugs don't start until 20 minutes after the heart has stopped."

The trial "raises as many questions as it answers," said Dr. Nisha Chandra-Strobos, chief of cardiology at the Bayview division of Johns Hopkins University.

The slow response time is one major reason, she said: "A time to injection of 21 minutes, the game is really over at that time."

The heart association guidelines which Ornato helped prepare apply only to the medical personnel called for emergency treatment of cardiac arrest. The heart association advises persons without medical training to call for that help as quickly as possible by dialing 911.

Emergency measures can be taken before medical help arrives. Newly updated advice by the heart association says that simply depressing the chest periodically and continually can contribute to survival. If the cardiac arrest occurs in a public place such as an airport, a portable defibrillator may be available. It should be placed against the chest to deliver an electric shock that might start the heart beating again.

More information

The symptoms of cardiac arrest and what to do about them are described by the American Heart Association.



SOURCES: Joseph P. Ornato, M.D., chairman, emergency medicine, Virginia Commonwealth University, Richmond, Va.; Nisha Chandra-Strobos, M.D., chief, cardiology, Johns Hopkins Bayview, Baltimore; July 3, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Two-Drug Combo Reduces Diabetic Kidney Damage
2. Two-Drug Combo Fights Brain Tumors
3. Glaucoma Treatment Can Prevent Blindness
4. TomoTherapy Concludes Treatment Quality Challenge
5. Best treatment for MS may depend on disease subtype
6. Expanded Seconds-Count.org Helps Physicians Navigate Spectrum of Cardiovascular Disease Treatment Options
7. ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of Probiotics
8. OptiNose presents data on highly effective migraine treatment
9. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
10. Treatment for Cigarette, Alcohol & Drug Use During Pregnancy Dramatically Improves Outcomes for Mom and Baby, Kaiser Permanente Study Shows
11. Rheumatoid Arthritis Treatment Guidelines Updated
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two-Drug Treatment Didn't Improve Cardiac Arrest Survival Rates
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) ... facility among higher education institutions in Hong Kong to support teaching, learning and research. ... range and quantity of facilities in Hong Kong. , With an area of ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... Joseph Health held the much anticipated Regional Primary Care Spring Symposium on April ... in the local medical community, offering physicians and healthcare providers an opportunity to ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Detroit reveals good news for older shoulder replacement patients; post-operative recovery just might ... from two groups of patients presenting with osteoarthritis following surgery: 262 patients under ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
Breaking Medicine Technology: